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Available online 22 May 2014The World Health Organization has proposed three major
challenges1 in patient safety: healthcare-associated infec-
tion (HAI); safe surgery saves lives; and antimicrobial
resistance. The first priority for patient safety is to confront
HAI, which obviously indicates that HAI has become an
important issue in global public health.
HAI remains a current challenge in Taiwan. HAI is an
important indicator that reflects healthcare quality and
patient safety. Moreover, HAI significantly increases
morbidity, mortality, and medical costs.2 According to the
published statistical data from the National Health In-
surance (NHI) of Taiwan in 2011, the estimated extra
medical costs of HAI cases are USD 0.92 billion (NTD 27.7
billion).3
A central line is an invasive medical device and invasive
procedures are high-risk factors leading to infection. Based
on global surveillance of patients with bloodstream in-
fections, urinary tract infections, or pneumonia, approxi-
mately 50% of patients are implanted with an invasive
medical device.4
According to the 2012 surveillance data, the rate of
central line associated bloodstream infections (CLABSI)
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line days, respectively.5 Hence, a government-lead force
combined with professional organizations promoting cen-
tral line care quality and creating patient safety is
imperative; the Centers for Disease Control, Taiwan
(Taiwan CDC) has started planning a national action plan
to eliminate CLABSI in Taiwand the central line care
quality improvement projectdsince 2012.6 The phases of
the central line care quality improvement project include
a planning phase, an executive phase, and a policy eval-
uation phase.
Planning phase
The pilot project on the reduction of CLABSI involved
applying bundle intervention of infection control from 2010
to 2011. This project consisted of a total of 29 ICU units
from 14 hospitals with a variety of levels and sizes. The rate
of CLABSI declined 11.2% from 5.81 to 5.16/1000 central
line days during the pilot period. The results suggest that a
coordinated, multi-institutional infection control initiative
might be an effective approach to reducing CLABSI. After
the pilot project, a national action plandcentral line care
quality improvement projectdis planned for 2012e2015
(Fig. 1). This project is to utilize the medical development
funds and collaborate with government, medical in-
stitutions, and professional organizations. Three major
executive directions including effective interventionby Elsevier Taiwan LLC. All rights reserved.
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annually planned and executed.
Effective intervention measures7
To implement the insertion bundle
The components of the insertion bundle include hand hy-
giene, maximum barrier precautions, use of chlorhexidine
for skin cleaning, avoidance of femoral site for central line,
and removal of unnecessary catheters.
To implement the maintenance bundle
The components of the maintenance bundle for CLABSI
include daily evaluation of catheter removal, hand hygiene,
changing aseptic dressings, scrub the hub, and changing the
extension tube and infusion device.
Financial incentive
The financial incentive is provided through an allowance
and incentive mechanism based on the following directions:
training, promotion, collection of quality indicators, and
pay for reporting. The establishment of an incentive system
can be used to elevate executive effectiveness via the
integration of government force and medical institutions.
Performance
The performance indicators are classified as process and
outcome. Through the collection, analysis, feedback of
performance indicators, implementation, and coordina-
tion, the effectiveness of the implemented strategy isFigure 1. Infrastructure of national action plandevaluated and provides medical institutions with a refer-
ence for future review.
Executive phase
The role of this project includes the establishment of
project management center, the establishment of model
hospitals in different regions, and the assessment of
participating hospitals in different regions. The four major
promotional strategies include engagement, education,
execution, and evaluation. The brief executive methods
are summarized as following:
The establishment of a project management center
The professional organization is entrusted as a project
management center and to establish a project team. The
team is responsible for assisting hospitals to promote the
central line care bundle measures, to conduct external
audit work and give advice, to evaluate the incentives, and
to improve the quality of healthcare personnel.
Regional development of model hospitals
A total of seven medical centers were selected to serve as
the model hospitals. Besides the internal promotional ac-
tivities, the model hospitals also have to serve as a standard
for participants in the districts. The training of seed
teachers, conference organization, field audits, bench-
marking, sharing of activities, and the assistance of
participating hospitals to promote the project are also
conducted by them.central line care quality improvement project.
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hospitals
A total of 57 hospitals are granted for promoting central
line care bundle measures, these include related medical
personnel training, the implementation and monitoring of
care bundle measures, process and outcome indicators
reporting.
Policy evaluation phase
The year 2015 is planned to be the policy evaluation phase
for the central line care quality project. Except the eval-
uation and improvement, the success of the experiences in
Taiwan are expected to be shared with others for refer-
ence. This is in order to achieve the combined use of the
existing NHI mechanism, to encourage hospitals in the
actual implementation of HAI control, to improve patient
safety and healthcare quality as well as the reduction of
national health expenses. The boost of the reward perfor-
mance index, involvement of NHI, and other performance
indexes for medical quality improvement plans are further
expected.
Challenges of HAI in Taiwan
The 2003 Severe Acute Respiratory Syndrome outbreak
marked a turning point in HAI control in Taiwan. Never-
theless, many challenges in HAI remain. The NHI system
covers a wide range of outpatient and inpatient services
and allows the people in Taiwan to have access to
comprehensive medical care. However, the introduction of
the system has also increased the numbers of bedridden
patients with long-term use of invasive medical devices and
procedures. This leads to an increased risk of acquiring
HAI.8,9 Moreover, there are two other major challenges,
including an increase in average life expectancy and the
growth of the elderly population, putting the population at
large at risk of infection. Furthermore, frequent interna-
tional travel also facilitates HAI across national borders,
posing a serious threat to the public. In the future, the
Taiwan CDC will continue to work with stakeholders to
promote and execute infection control strategies in order
to achieve our ultimate goal of zero tolerance to HAI.10
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